Skip to main content
. 2017 Jul 26;313(4):F997–F1004. doi: 10.1152/ajprenal.00186.2017

Fig. 4.

Fig. 4.

Histone deacetylase 6 (HDAC6) inhibition decreases HDAC6 activity. A: Western blot showing expression of HDAC6 in treated or control cells. Ezrin was used as a loading control. B: summary data for Western blots show that the steady-state levels of HDAC6 are higher in PN cells than in PKD1 heterozygous (PH) cells. C: HDAC activity in PN/PH cells treated with ACY-1215 or DMSO for 16 h was measured using a HDAC chemiluminescent assay kit (no. 50076; BPS Bio Sciences). Fluorescence was measured at 360 nm excitation and 450 nm emission using a SpectraMax M3 microplate reader. Undiluted cell lysates were used in place of enzyme. Note that ACY-1215 reduces HDAC6 activity. Bars represent means ± SE of the HDAC6 expression. The experiment was repeated 3 times. ** P < 0.01 and ****P < 0.0001. Data were analyzed by nonparametric t-test.